Fingerprint
Dive into the research topics of 'Rituximab therapy for refractory orbital inflammation results of a phase 1/2, dose-ranging, randomized clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rituximab therapy for refractory orbital inflammation results of a phase 1/2, dose-ranging, randomized clinical trial
Eric B. Suhler, Lyndell L. Lim, Robert M. Beardsley, Tracy R. Giles, Sirichai Pasadhika, Shelly T. Lee, Alexandre De Saint Sardos, Nicholas J. Butler, Justine R. Smith, James T. Rosenbaum
Research output: Contribution to journal › Article › peer-review
59
Scopus
citations